The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
the causative agent of the ongoing pandemic of coronavirus disease 2019 (COVID-19). The …

Objectives The coronavirus disease 2019 (COVID-19), caused by the novel betacoronavirus
severe acute respiratory syndrome 2 (SARS-CoV-2), was declared a pandemic in March …

Background COVID-19 is a pandemic with no specific antiviral treatments or vaccines. The
urgent needs for exploring the neutralizing antibodies from patients with different clinical …

Summary The World Health Organization has declared the ongoing outbreak of COVID-19,
which is caused by a novel coronavirus SARS-CoV-2, a pandemic. There is currently a lack …

To assess the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) antibodies produced by natural infection and describe the serological characteristics over …

While the antibody response to SARS-CoV-2 has been extensively studied in blood,
relatively little is known about the antibody response in saliva and its relationship to systemic …

Summary SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating
worldwide pandemic, and there is a pressing need to understand the development …

Introduction The longevity of antibody levels against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and the duration of immunity are current topics of major …

Antibodies, and the B cell and plasma cell populations responsible for their production, are
key components of the human immune system's response to SARS-CoV-2, which has …

The current practice for diagnosis of SARS-CoV-2 infection relies on PCR testing of
nasopharyngeal or respiratory specimens in a symptomatic patient at high epidemiologic …